BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32633885)

  • 21. The important roles of protein SUMOylation in the occurrence and development of leukemia and clinical implications.
    Zhao B; Zhang Z; Chen X; Shen Y; Qin Y; Yang X; Xing Z; Zhang S; Long X; Zhang Y; An S; Wu H; Qi Y
    J Cell Physiol; 2021 May; 236(5):3466-3480. PubMed ID: 33151565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sumoylation dynamics during keratinocyte differentiation.
    Deyrieux AF; Rosas-Acosta G; Ozbun MA; Wilson VG
    J Cell Sci; 2007 Jan; 120(Pt 1):125-36. PubMed ID: 17164289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.
    Impens F; Radoshevich L; Cossart P; Ribet D
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12432-7. PubMed ID: 25114211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
    Yang WS; Campbell M; Kung HJ; Chang PC
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation.
    Licciardello MP; Müllner MK; Dürnberger G; Kerzendorfer C; Boidol B; Trefzer C; Sdelci S; Berg T; Penz T; Schuster M; Bock C; Kralovics R; Superti-Furga G; Colinge J; Nijman SM; Kubicek S
    Oncogene; 2015 Jul; 34(29):3780-90. PubMed ID: 25263445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assay methods for small ubiquitin-like modifier (SUMO)-SUMO-interacting motif (SIM) interactions in vivo and in vitro using a split-luciferase complementation system.
    Hirohama M; Voet AR; Ozawa T; Saitoh H; Nakao Y; Zhang KY; Ito A; Yoshida M
    Anal Biochem; 2014 Mar; 448():92-4. PubMed ID: 24333278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performing in vitro sumoylation reactions using recombinant enzymes.
    Werner A; Moutty MC; Möller U; Melchior F
    Methods Mol Biol; 2009; 497():187-99. PubMed ID: 19107418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
    Watanabe M; Itoh K
    Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Covalent conjugation of the equine infectious anemia virus Gag with SUMO.
    Wang J; Wen S; Zhao R; Qi J; Liu Z; Li W; An J; Wood C; Wang Y
    Biochem Biophys Res Commun; 2017 May; 486(3):712-719. PubMed ID: 28342872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-Time Surface Plasmon Resonance (SPR) for the Analysis of Interactions Between SUMO Traps and Mono- or PolySUMO Moieties.
    Xolalpa W; Rodriguez MS; England P
    Methods Mol Biol; 2016; 1475():99-107. PubMed ID: 27631800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMO: getting it on.
    Anckar J; Sistonen L
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct functional modes of SUMOylation for retinoid X receptor alpha.
    Lee WP; Jena S; Rodriguez EP; O'Donovan SP; Wagner C; Jurutka PW; Thompson PD
    Biochem Biophys Res Commun; 2015 Aug; 464(1):195-200. PubMed ID: 26116533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of sumoylated substrates for biochemical analysis.
    Knipscheer P; Klug H; Sixma TK; Pichler A
    Methods Mol Biol; 2009; 497():201-10. PubMed ID: 19107419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes.
    Bossis G; Melchior F
    Mol Cell; 2006 Feb; 21(3):349-57. PubMed ID: 16455490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive and negative regulation of APP amyloidogenesis by sumoylation.
    Li Y; Wang H; Wang S; Quon D; Liu YW; Cordell B
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):259-64. PubMed ID: 12506199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The small ubiquitin-like modifier (SUMO)-conjugating system of Toxoplasma gondii.
    Braun L; Cannella D; Pinheiro AM; Kieffer S; Belrhali H; Garin J; Hakimi MA
    Int J Parasitol; 2009 Jan; 39(1):81-90. PubMed ID: 18761012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An extended consensus motif enhances the specificity of substrate modification by SUMO.
    Yang SH; Galanis A; Witty J; Sharrocks AD
    EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interplay of the fungal sumoylation network for control of multicellular development.
    Harting R; Bayram O; Laubinger K; Valerius O; Braus GH
    Mol Microbiol; 2013 Dec; 90(5):1125-45. PubMed ID: 24279728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sumoylation regulates EXO1 stability and processing of DNA damage.
    Bologna S; Altmannova V; Valtorta E; Koenig C; Liberali P; Gentili C; Anrather D; Ammerer G; Pelkmans L; Krejci L; Ferrari S
    Cell Cycle; 2015 Aug; 14(15):2439-50. PubMed ID: 26083678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.